ArticleJournal of healthcare engineering2022
An Intelligent and Reliable Hyperparameter Optimization Machine Learning Model for Early Heart Disease Assessment Using Imperative Risk Attributes.
Article in Journal of healthcare engineering, 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. It has been retracted, and should not be counted. Cited by 4 papers, 1 of them a synthesis that pooled it.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
4 citing papers in PubMed, 1 synthesis or guideline pooled it.
- Prediction performance of the machine learning model in predicting mortality risk in patients with traumatic brain injuries: a systematic review and meta-analysis.BMC medical informatics and decision making · 2023Pooled it
- A comprehensive survey of artificial intelligence methods for cardiovascular disease detection: Recent advances and future challenges.MethodsX · 2025Review
- Asynchronous Federated Learning for Improved Cardiovascular Disease Prediction Using Artificial Intelligence.Diagnostics (Basel, Switzerland) · 2023Article
- Retracted: An Intelligent and Reliable Hyperparameter Optimization Machine Learning Model for Early Heart Disease Assessment Using Imperative Risk Attributes.Journal of healthcare engineering · 2023Article
Corrections and comments
- Retraction · 2023-10-11Concerns/Issues about Data · Concerns/Issues about Results and/or Conclusions · Concerns/Issues about Referencing/Attributions · Concerns/Issues about Peer Review · Investigation by Journal/Publisher · Investigation by Third Party · Paper Mill · Computer-Aided Content or Computer-Generated Content · Unreliable Results and/or Conclusions ·
- Retracted
Authors and funding
6 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Heart disease is a severe disorder, which inflicts an adverse burden on all societies and leads to prolonged suffering and disability. We developed a risk evaluation model based on visible low-cost significant noninvasive attributes using hyperparameter optimization of machine learning techniques. The multiple set of risk attributes is selected and ranked by the recursive feature elimination technique. The assigned rank and value to each attribute are validated and approved by the choice of medical domain experts. The enhancements of applying specific optimized techniques like decision tree, k-nearest neighbor, random forest, and support vector machine to the risk attributes are tested. Experimental results show that the optimized random forest risk model outperforms other models with the highest sensitivity, specificity, precision, accuracy, AUROC score, and minimum misclassification rate. We simulate the results with the prevailing research; they show that it can do better than the existing risk assessment models with exceptional predictive accuracy. The model is applicable in rural areas where people lack an adequate supply of primary healthcare services and encounter barriers to benefit from integrated elementary healthcare advances for initial prediction. Although this research develops a low-cost risk evaluation model, additional research is needed to understand newly identified discoveries about the disease.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.